From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Will Optibiotix make a profit next year? Emails with Steve O’Hara on whose numbers the shares might quadruple within 18 months

By Tom Winnifrith | Thursday 22 August 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


You may well say that this a question I have posed more or less every year for the past half decade. And I have been hopeful only for those hopes to be dashed. Mr. Market feels the same way and that is why shares in Optibiotix (OPTI) are, at, just 24.25p.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Tom

Photo Article from Sharestock: tea

Wednesday »

Bearcast

Tom Winnifrith Bearcast: red flags and bubbles

 

SDI

SDI Group – again a Buy?

 

Tom

Feeling Thirsty Evil Banksta?

Time left: 15:23:17